Clementia Pharmaceuticals logo
Exited company

Clementia Pharmaceuticals

Details
Region
Quebec
Industry sector
Drugs
Investment year
2012
Fund
Healthcare Venture Fund
Learn more
Our partnership

Clementia is a BDC Capital Healthcare Venture Fund company, co-managed in partnership by Amplitude Venture Capital.

Contact

Jean-François Pariseau, Founding Partner at Amplitude Venture Capital

About the company

Clementia is a developing Retinoic acid receptor gamma agonists (RARγ) to address diseases of heterotopic ossification, including Fibrodysplasia Ossificans Progressiva. The company was acquired by Ipsen in 2019.

Your privacy

BDC uses cookies to improve your experience on its website and for advertising purposes, to offer you products or services that are relevant to you. By clicking ῝I understand῎ or by continuing to browse this site, you consent to their use.

To find out more, consult our Policy on confidentiality.